case study cover

Speeding Up Antibody Discovery for Infectious Disease

DARPA tasks Vanderbilt University Medical Center to significantly reduce the time to develop antibodies. Twist Bioscience's high-throughput, synthetic genes have expedited the process.

Speeding Up Antibody Discovery for Infectious Disease

DARPA tasks Vanderbilt University Medical Center to significantly reduce the time to develop antibodies. Twist Bioscience's high-throughput, synthetic genes have expedited the process.

/sites/default/files/2019-10/CaseStudy_Vanderbilt_010819-FINAL.pdf

 

You'll learn how

 

  • Institutions like VUMC are advancing DARPA’s Pandemic Protection Platform (P3)

  • VUMC accelerates antibody identification to 60 days

  • New synthetic DNA technology speeds up the antibody discovery process

antibody development timeline

Read preview

case study page 2

Dive into the Case Study

 

About Vanderbilt University Medical Center

The Vanderbilt medical complex in Nashville, Tennessee, is a leader in patient care, medical education, nursing education, and research.